Bladder EpiCheck for detecting bladder cancer recurrence

Equality considerations

NICE is committed to promoting equality of opportunity, eliminating unlawful discrimination and fostering good relations between people with particular protected characteristics and others.

Bladder cancer is more common in men than women; 73% of cases in the UK are in men, and 27% are in women. Despite a lower incidence of bladder cancer in women, rates of survival are lower for women than for men. It mainly affects older people, with the highest incidence rates in people aged 85 to 89 years for women and 90 years and over for men (Cancer Research UK, 2018). People of European family origin have a much higher risk of developing bladder cancer than those of African American, Hispanic or Asian family origin. People with cancer are protected under the Equality Act 2010 from the point of diagnosis. Age, sex and race are protected characteristics under the Equality Act 2010.